Elevated levels of IFN-γ, IL-12, IL-15, and IL-18 are linked to favorable CRC outcomes, while IL-4, IL-6, IL-17, TNF, TGF-β, and VEGF indicate tumor progression (48–52). This evidence concerns the gene IL17A and neoplasm.